CoChat

The Androgen Axis in Recurrent Prostate Cancer

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

Purpose. Prostate cancer that recurs during androgen deprivation therapy is referred to as androgen-independent. High levels of expression of androgen receptor and androgen receptor-regulated genes in recurrent prostate cancer suggest a role for androgen receptor and its ligands in prostate cancer recurrence. Experimental Design. Recurrent prostate cancer specimens from 22 men whose prostate cancer recurred locally during androgen deprivation therapy and benign prostate specimens from 48 men who had received no prior treatment were studied. Androgen receptor expression was measured using monoclonal antibody and automated digital video image analysis. Tissue androgens were measured using radioimmunoassay. Results. Epithelial nuclei androgen receptor immunostaining in recurrent prostate cancer (mean optical density, 0.284 ± SD 0.115 and percentage positive nuclei, 83.7 ± 11.6) was similar to benign prostate (mean optical density, 0.315 ± 0.044 and percentage positive nuclei, 77.3 ± 13.0). Tissue levels of testosterone were similar in recurrent prostate cancer (2.78 ± 2.34 pmol/g tissue) and benign prostate (3.26 ± 2.66 pmol/g tissue). Tissue levels of dihydrotestosterone, dehydroepiandrosterone, and androstenedione were lower (Wilcoxon, P = 0.0000068, 0.00093, and 0.0089, respectively) in recurrent prostate cancer than in benign prostate, and mean dihydrotestosterone levels, although reduced, remained 1.45 nm. Androgen receptor activation in recurrent prostate cancer was suggested by the androgen-regulated gene product, prostate-specific antigen, at 8.80 ± 10.80 nmol/g tissue. Conclusions. Testosterone and dihydrotestosterone occur in recurrent prostate cancer tissue at levels sufficient to activate androgen receptor. Novel therapies for recurrent prostate cancer should target androgen receptor directly and prevent the formation of androgens within prostate cancer tissue.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-1146-03

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 69 references

Cited by

See all 680

Metadata

Authors
Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • 2Pathology and Laboratory Medicine,
  • 1Departments of Surgery (Division of Urology),
  • 3Pediatrics (Laboratories for Reproductive Biology),
  • 4Cell and Developmental Biology, and
Venue
Clinical Cancer Research
Published
2004-01-15
Volume
10
Issue
2
Pages
440-448
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2140855177
Cited by
675
References
68
Citations by year
2025: 4 · 2024: 10 · 2023: 28 · 2022: 11 · 2021: 16 · 2020: 11 · 2019: 17 · 2018: 25 · 2017: 23 · 2016: 38 · 2015: 44 · 2014: 45 · 2013: 55 · 2012: 50
FWCI
23.21
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (CA-77739, P01CA077739)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54-HD-35041, U54HD035041)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
recurrent prostate cancer, castration-resistant prostate cancer, androgen receptor, androgen deprivation therapy, dihydrotestosterone, testosterone, androgen receptor activation, prostate-specific antigen, androgen-regulated gene expression, androgen production
MeSH terms
Aged, Aged, 80 and over, Androgens, Androstenedione, Antibodies, Monoclonal, Cell Nucleus, Dehydroepiandrosterone, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Male, Middle Aged, Prostate, Prostatic Neoplasms, Radioimmunoassay, Receptors, Androgen, Recurrence, Dihydrotestosterone, Prostate-Specific Antigen, Microscopy, Video

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Androgen Axis in Recurrent Prostate Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-1146-03
The paper
Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004). The Androgen Axis in Recurrent Prostate Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-1146-03

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.